US2010081154A1PendingUtilityA1

IDENTIFICATION AND USE OF BACTERIAL [2Fe-2S] DIHYDROXY-ACID DEHYDRATASES

Assignee: BUTAMAX TM ADVANCED BIOFUELS LPriority: Sep 29, 2008Filed: Sep 29, 2009Published: Apr 1, 2010
Est. expirySep 29, 2028(~2.2 yrs left)· nominal 20-yr term from priority
C12N 15/81C12N 15/52C12N 9/88C12N 15/74G16B 30/10G16B 30/00C12P 7/16C12P 13/06Y02E50/10C12P 7/40C12Y 402/01009C12P 13/08
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A group of bacterial dihydroxy-acid dehydratases having a [2Fe-2S] cluster was discovered. Bacterial [2Fe-2S] DHADs were expressed as heterologous proteins in bacteria and yeast cells, providing DHAD activity for conversion of 2,3-dihydroxyisovalerate to α-ketoisovalerate or 2,3-dihydroxymethylvalerate to α-ketomethylvalerate. Isobutanol and other compounds may be synthesized in pathways that include bacterial [2Fe-2S] DHAD activity.

Claims

exact text as granted — not AI-modified
1 . A method for identifying [2Fe-2S] DHAD enzymes comprising:
 a) querying one or more amino acid sequences with a Profile Hidden Markov Model prepared using the proteins of SEQ ID NOs:164, 168, 230, 232, 298, 310, 344, and 346, wherein a match with an E-value of less than 10 −5  provides a first subset of sequences whereby said first subset of sequences correspond to one or more DHAD related proteins;   b) analyzing the first subset of sequences that correspond to one or more DHAD related proteins of step (a) for the presence of three conserved cysteines that correspond to positions 56, 129, and 201 in the  Streptococcus mutans  dihydroxy-acid dehydratase amino acid sequence (SEQ ID NO: 168) whereby a second subset of sequences encoding [2Fe-2S] DHAD enzymes are identified; and   c) analyzing the second subset of sequences of step (b) for the presence of signature conserved amino acids at positions corresponding to positions in the  Streptococcus mutans  DHAD amino acid sequence (SEQ ID NO: 168) that are aspartic acid at position 88, arginine or asparagine at position 142, asparagine at position 208, and leucine at position 454 whereby a third subset of sequences encoding [2Fe-2S] DHAD enzymes are further identified.   
     
     
         2 . The method of  claim 1  further comprising
 d) expressing a polypeptide having a sequence identifiable by any one or all of steps a), b), and c) in a cell; and   e) confirming that said polypeptide has DHAD activity in the cell.   
     
     
         3 . The method of  claim 1  further comprising
 d) purifying a protein encoded by a sequence identifiable by any one or all of steps a), b), and c); and   e) confirming that said protein is a [2Fe-2S] DHAD enzyme by UV-vis and EPR spectroscopy.   
     
     
         4 . The method of  claim 1  further comprising selecting one or more sequences corresponding to bacterial [2Fe-2S] DHAD enzyme sequences identified in any one or all of steps a), b), and c). 
     
     
         5 . The method of  claim 2  wherein the cell lacks endogenous DHAD activity. 
     
     
         6 . The method of  claim 4  further comprising
 d) expressing said selected one or more sequences corresponding to bacterial [2Fe-2S] DHAD enzyme sequences in a cell; and   e) confirming that said enzyme sequence has DHAD activity in the cell.   
     
     
         7 . The method of  claim 4  further comprising
 d) purifying a protein encoded by said selected one or more sequences corresponding to bacterial [2Fe-2S] DHAD enzyme sequences whereby a purified protein is produced; and   e) confirming that the protein is a [2Fe-2S] DHAD enzyme by UV-vis and EPR spectroscopy.   
     
     
         8 . A microbial host cell comprising at least one heterologous [2Fe-2S] DHAD enzyme identifiable by the method of any one of  claims 1 - 7 . 
     
     
         9 . The microbial host cell of  claim 8  wherein the cell is bacterial cell or a yeast cell. 
     
     
         10 . The microbial host cell of  claim 9  wherein the bacterial host cell is a member of a genus of bacteria selected from the group consisting of  Clostridium, Zymomonas, Escherichia, Salmonella, Rhodococcus, Pseudomonas, Bacillus, Lactobacillus, Enterococcus, Pediococcus, Alcaligenes, Klebsiella, Paenibacillus, Arthrobacter, Corynebacterium , and  Brevibacterium, Lactococcus, Leuconostoc, Oenococcus, Pediococcus , and  Streptococcus.    
     
     
         11 . The microbial host cell of  claim 9  wherein the yeast cells a member of a genus of yeast selected from the group consisting of  Saccharomyces, Schizosaccharomyces, Hansenula, Candida, Kluyveromyces, Yarrowia  and  Pichia.    
     
     
         12 . The microbial host cell of  claim 8  wherein the cell produces isobutanol. 
     
     
         13 . A method for the production of isobutanol comprising:
 a) providing the microbial host cell of  claim 8  wherein said host cell comprises an isobutanol biosynthetic pathway; and   b) growing the host cell of step (a) under conditions wherein isobutanol is produced.   
     
     
         14 . A method for the conversion of 2,3-dihydroxyisovalerate to α-ketoisovalerate comprising:
 a) providing the microbial host of  claim 8  and a source of 2,3-dihydroxyisovalerate; and   b) growing the microbial host cell of (a) under conditions where the 2,3-dihydroxyisovalerate is converted to α-ketoisovalerate.

Join the waitlist — get patent alerts

Track US2010081154A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.